Inovio Pharmaceuticals Inc (INO)

[Ubertino]

Why Inovio Pharmaceuticals (INO) Stock Might be a Great Pick

December 05, 2014

by Zacks Equity Research Published on December 05, 2014

One stock that might be an intriguing choice for investors right now is Inovio Pharmaceuticals, Inc. (INO - Snapshot Report). This is because this security in the medical space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.

This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. This is arguably taking place in the medical space as it currently has a Zacks Industry Rank of 55 out of more than 250 industries, suggesting it is well-positioned from this perspective, especially when compared to other segments out there.

Meanwhile, Inovio Pharmaceuticals is actually looking pretty good on its own too. The firm has seen solid earnings estimate revision activity over the past month, suggesting analysts are becoming a bit more bullish on the firm’s prospects in both the short and long term.

In fact, over the past month, current quarter estimates have narrowed from a loss of 12 cents a share to a loss of 3 cents a share, while current year estimates have narrowed from a loss of 72 cents per share to a loss of 60 cents per share. This has helped INO to earn a Zacks Rank #2 (Buy), further underscoring the company’s solid position.

So, if you are looking for a decent pick in a strong industry, consider Inovio Pharmaceuticals. Not only is its industry currently in the top third, but it is seeing solid estimate revisions as of late, suggesting it could be a very interesting choice for investors seeking a name in this great industry segment.

http://www.zacks.com/stock/news/156384/why-inovio-pharmaceuticals-ino-stock-might-be-a-great-pick